FREKA TRELUMINA szonda alkalmazása pancreatoduodenectomiát követoen.

Translated title of the contribution: Use of FREKA TRELUMINA tube after pancreatoduodenectomy

Judit Hallay, Csaba Micskei, B. Fülesdi, Gábor Kovács, Zsolt Szentkereszty, István Takács, Péter Arkosy, S. Sipka, P. Sápy

Research output: Contribution to journalArticle

Abstract

Patients operated on for pancreas head cancer were investigated postoperatively. Fifteen patients (Group I) were treated with FREKA TRELUMINA tube (they benefited of safe gastric emptying and jejunal feeding), 5 patients (Group II) did not receive this treatment. Laboratory results were measured preoperatively, on the first, 4th and 10th days. Bowel movements were monitored. All patients were received Total Parenteral Nutrition--25 kcal/kg/day. Group I received on the first postoperative day 500 ml tea, from the second day we gradually increased the oral intake to a maximum of 1500 mls. Patients in Group II were fed only parenterally. RESULTS: In Group I the first bowel sounds could be heard on the 3rd postoperative day, the first stool was detected on the 3rd-4th. Laboratory results of the first postoperative day were compared to results of the 10th day. Serum protein changed from 47.7 to 59 g/l (p <0.001), albumin rose from 26.9 to 32.5 g/l (p <0.012), C-reactive protein reduced from 119.7 to 66.05 mg/l (p <0.014). Changes in retinol-binding protein, prealbumin and immunoglobulin were not significant. In Group II were no significant laboratory changes. First bowel movements were detected on the 8th day. Clinical stay was no longer than in Group I. Though FREKA TRELUMINA delays natural gastric emptying, it enables early enteral nutrition, patients feel better with increased peristalsis, and the use of the tube is cost-effective.

Original languageHungarian
Pages (from-to)402-405
Number of pages4
JournalMagyar sebészet
Volume58
Issue number6
Publication statusPublished - 2005

Fingerprint

Pancreaticoduodenectomy
Gastric Emptying
Peristalsis
Retinol-Binding Proteins
Prealbumin
Total Parenteral Nutrition
Enteral Nutrition
Tea
Head and Neck Neoplasms
Pancreatic Neoplasms
C-Reactive Protein
Immunoglobulins
Blood Proteins
Albumins
Costs and Cost Analysis

Cite this

Hallay, J., Micskei, C., Fülesdi, B., Kovács, G., Szentkereszty, Z., Takács, I., ... Sápy, P. (2005). FREKA TRELUMINA szonda alkalmazása pancreatoduodenectomiát követoen. Magyar sebészet, 58(6), 402-405.

FREKA TRELUMINA szonda alkalmazása pancreatoduodenectomiát követoen. / Hallay, Judit; Micskei, Csaba; Fülesdi, B.; Kovács, Gábor; Szentkereszty, Zsolt; Takács, István; Arkosy, Péter; Sipka, S.; Sápy, P.

In: Magyar sebészet, Vol. 58, No. 6, 2005, p. 402-405.

Research output: Contribution to journalArticle

Hallay, J, Micskei, C, Fülesdi, B, Kovács, G, Szentkereszty, Z, Takács, I, Arkosy, P, Sipka, S & Sápy, P 2005, 'FREKA TRELUMINA szonda alkalmazása pancreatoduodenectomiát követoen.', Magyar sebészet, vol. 58, no. 6, pp. 402-405.
Hallay J, Micskei C, Fülesdi B, Kovács G, Szentkereszty Z, Takács I et al. FREKA TRELUMINA szonda alkalmazása pancreatoduodenectomiát követoen. Magyar sebészet. 2005;58(6):402-405.
Hallay, Judit ; Micskei, Csaba ; Fülesdi, B. ; Kovács, Gábor ; Szentkereszty, Zsolt ; Takács, István ; Arkosy, Péter ; Sipka, S. ; Sápy, P. / FREKA TRELUMINA szonda alkalmazása pancreatoduodenectomiát követoen. In: Magyar sebészet. 2005 ; Vol. 58, No. 6. pp. 402-405.
@article{6e2f605a86eb4d1db489a39d3ab3b26e,
title = "FREKA TRELUMINA szonda alkalmaz{\'a}sa pancreatoduodenectomi{\'a}t k{\"o}vetoen.",
abstract = "Patients operated on for pancreas head cancer were investigated postoperatively. Fifteen patients (Group I) were treated with FREKA TRELUMINA tube (they benefited of safe gastric emptying and jejunal feeding), 5 patients (Group II) did not receive this treatment. Laboratory results were measured preoperatively, on the first, 4th and 10th days. Bowel movements were monitored. All patients were received Total Parenteral Nutrition--25 kcal/kg/day. Group I received on the first postoperative day 500 ml tea, from the second day we gradually increased the oral intake to a maximum of 1500 mls. Patients in Group II were fed only parenterally. RESULTS: In Group I the first bowel sounds could be heard on the 3rd postoperative day, the first stool was detected on the 3rd-4th. Laboratory results of the first postoperative day were compared to results of the 10th day. Serum protein changed from 47.7 to 59 g/l (p <0.001), albumin rose from 26.9 to 32.5 g/l (p <0.012), C-reactive protein reduced from 119.7 to 66.05 mg/l (p <0.014). Changes in retinol-binding protein, prealbumin and immunoglobulin were not significant. In Group II were no significant laboratory changes. First bowel movements were detected on the 8th day. Clinical stay was no longer than in Group I. Though FREKA TRELUMINA delays natural gastric emptying, it enables early enteral nutrition, patients feel better with increased peristalsis, and the use of the tube is cost-effective.",
author = "Judit Hallay and Csaba Micskei and B. F{\"u}lesdi and G{\'a}bor Kov{\'a}cs and Zsolt Szentkereszty and Istv{\'a}n Tak{\'a}cs and P{\'e}ter Arkosy and S. Sipka and P. S{\'a}py",
year = "2005",
language = "Hungarian",
volume = "58",
pages = "402--405",
journal = "Magyar Sebeszet",
issn = "0025-0295",
publisher = "Ifjusagi Lapkiado Vallalat",
number = "6",

}

TY - JOUR

T1 - FREKA TRELUMINA szonda alkalmazása pancreatoduodenectomiát követoen.

AU - Hallay, Judit

AU - Micskei, Csaba

AU - Fülesdi, B.

AU - Kovács, Gábor

AU - Szentkereszty, Zsolt

AU - Takács, István

AU - Arkosy, Péter

AU - Sipka, S.

AU - Sápy, P.

PY - 2005

Y1 - 2005

N2 - Patients operated on for pancreas head cancer were investigated postoperatively. Fifteen patients (Group I) were treated with FREKA TRELUMINA tube (they benefited of safe gastric emptying and jejunal feeding), 5 patients (Group II) did not receive this treatment. Laboratory results were measured preoperatively, on the first, 4th and 10th days. Bowel movements were monitored. All patients were received Total Parenteral Nutrition--25 kcal/kg/day. Group I received on the first postoperative day 500 ml tea, from the second day we gradually increased the oral intake to a maximum of 1500 mls. Patients in Group II were fed only parenterally. RESULTS: In Group I the first bowel sounds could be heard on the 3rd postoperative day, the first stool was detected on the 3rd-4th. Laboratory results of the first postoperative day were compared to results of the 10th day. Serum protein changed from 47.7 to 59 g/l (p <0.001), albumin rose from 26.9 to 32.5 g/l (p <0.012), C-reactive protein reduced from 119.7 to 66.05 mg/l (p <0.014). Changes in retinol-binding protein, prealbumin and immunoglobulin were not significant. In Group II were no significant laboratory changes. First bowel movements were detected on the 8th day. Clinical stay was no longer than in Group I. Though FREKA TRELUMINA delays natural gastric emptying, it enables early enteral nutrition, patients feel better with increased peristalsis, and the use of the tube is cost-effective.

AB - Patients operated on for pancreas head cancer were investigated postoperatively. Fifteen patients (Group I) were treated with FREKA TRELUMINA tube (they benefited of safe gastric emptying and jejunal feeding), 5 patients (Group II) did not receive this treatment. Laboratory results were measured preoperatively, on the first, 4th and 10th days. Bowel movements were monitored. All patients were received Total Parenteral Nutrition--25 kcal/kg/day. Group I received on the first postoperative day 500 ml tea, from the second day we gradually increased the oral intake to a maximum of 1500 mls. Patients in Group II were fed only parenterally. RESULTS: In Group I the first bowel sounds could be heard on the 3rd postoperative day, the first stool was detected on the 3rd-4th. Laboratory results of the first postoperative day were compared to results of the 10th day. Serum protein changed from 47.7 to 59 g/l (p <0.001), albumin rose from 26.9 to 32.5 g/l (p <0.012), C-reactive protein reduced from 119.7 to 66.05 mg/l (p <0.014). Changes in retinol-binding protein, prealbumin and immunoglobulin were not significant. In Group II were no significant laboratory changes. First bowel movements were detected on the 8th day. Clinical stay was no longer than in Group I. Though FREKA TRELUMINA delays natural gastric emptying, it enables early enteral nutrition, patients feel better with increased peristalsis, and the use of the tube is cost-effective.

UR - http://www.scopus.com/inward/record.url?scp=33645933283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645933283&partnerID=8YFLogxK

M3 - Article

C2 - 16550802

AN - SCOPUS:33645933283

VL - 58

SP - 402

EP - 405

JO - Magyar Sebeszet

JF - Magyar Sebeszet

SN - 0025-0295

IS - 6

ER -